Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Northwestern University
With
Ann & Robert H Lurie Children's Hospital of Chicago
Potential subjects came to the for a screening visit. Eligible subjects had baseline assessments performed and were provided study medication, allantoin 3% cream. Subjects were instructed to apply the study medication to the entire body once daily and to keep daily record of study medication use. Subjects returned every 4 weeks for a total of 12 weeks for repeat assessments.
Age
0–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
history of epidermolysis bullosa
You may not be if
use of any skin product containing allantoin for 30 days prior to enrollment
Clareo Health | Study of Alwextin® Cream in Treating Epidermolysis Bullosa
